Tags: Drug.
Tarenflurbil or R-flurbiprofen is the single enantiomer of the racemate NSAID flurbiprofen. For several years research and trials for the drug were conducted by Myriad Genetics to investigate its potential as a treatment for Alzheimer’s disease; that investigation concluded in June 2008 when the company announced it would discontinue development of the compound.